NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Qiagen N.V. QGEN | NYSE

$42.04 -$1.72 | -3.93%
SIGNAL:Signal available — unlock to view |2026-10-01 |F&G 50 |RSI 43.6

Company Overview:

Market Cap: $8.67B
Trailing PE: 21.3x
FWD PE *: 16.8x
Payout Ratio (TTM): 13.3%
52-Week Range: $32.53 - $57.82

* Forward PE is based on street estimates.

10 Year QGEN Performance Metrics:

Total Return (with DRIP): 72.0% (5.58% CAGR)
Total Return (no DRIP): 69.9% (5.44% CAGR)
Share Price: 47.4% (3.95% CAGR)
Yield on Cost (with DRIP): 1.43%
Total Invested: $10,000
Total Value (with DRIP): $17,204
Total Return $ (with DRIP): $7,204
Dividend Increase: -74.2% (-13.37% CAGR)
Dividend Yield (FWD): 0.83% ($0.35)
QGEN 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
QGEN Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
QGEN Price CAGR:1Y: -9.24%2Y: -2.12%5Y: -3.93%10Y: 3.89%
QGEN Dividend Charts
QGEN - Dividends
QGEN Dividend CAGR:1Y: -59.85%2Y: -41.60%5Y: -13.37%10Y: -13.37%
QGEN - Dividend Payout Ratio
QGEN Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
QGEN - Dividend to Free Cash Flow Ratio
QGEN Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

QGEN Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

QGEN - Revenue
QGEN Revenue CAGR:1Y: 0.28%2Y: 3.82%5Y: -1.16%10Y: 4.81%
QGEN - Earnings Per Share (EPS)
QGEN EPS CAGR:1Y: 13.64%2Y: 0.00%5Y: -0.78%10Y: 18.71%
QGEN - Net Income
🔓 See the full chart40% off right now · 7-day free trial
QGEN Net Income CAGR:1Y: 7.43%2Y: 0.00%5Y: -3.10%10Y: 17.13%
QGEN - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
QGEN EBITDA CAGR:1Y: 9.80%2Y: 0.00%5Y: -1.60%10Y: 9.06%
QGEN - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
QGEN Free Cash Flow CAGR:1Y: 30.81%2Y: 11.15%5Y: 7.46%10Y: 7.99%
QGEN - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
QGEN Free Cash Flow / Share CAGR:1Y: 37.29%2Y: 15.28%5Y: 9.67%10Y: 9.40%
QGEN - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
QGEN Operating Income CAGR:1Y: 15.54%2Y: 0.00%5Y: -2.67%10Y: 16.79%
QGEN - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
QGEN Gross Profit CAGR:1Y: 1.82%2Y: 212.91%5Y: -1.61%10Y: 4.91%
QGEN - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
QGEN Shares Outstanding CAGR:1Y: -4.75%2Y: -3.24%5Y: -2.17%10Y: -1.37%
QGEN - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
QGEN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
QGEN - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
QGEN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
QGEN - Expenses
🔓 See the full chart40% off right now · 7-day free trial
QGEN Expenses CAGR:1Y: 5.13%2Y: 5.04%5Y: -1.50%10Y: 5.16%
QGEN - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
QGEN - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
QGEN - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
QGEN - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
QGEN - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
QGEN - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

QGEN - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
QGEN Actual Revenue CAGR:1Y: 0.28%2Y: 3.82%5Y: -1.16%10Y: 4.81%
QGEN - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
QGEN Actual EPS CAGR:1Y: 13.64%2Y: 0.00%5Y: -0.78%10Y: 18.71%
QGEN - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
QGEN Actual Net Income CAGR:1Y: 7.43%2Y: 0.00%5Y: -3.10%10Y: 17.13%
QGEN - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
QGEN Actual EBITDA CAGR:1Y: 9.80%2Y: 0.00%5Y: -1.60%10Y: 9.06%

Ratios, Profit Margins & Return on Capital:

QGEN - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
QGEN Net Profit Margin CAGR:1Y: 7.15%2Y: 0.00%5Y: -1.96%10Y: 11.76%
QGEN - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
QGEN Gross Profit Margin CAGR:1Y: 1.55%2Y: 201.47%5Y: -0.45%10Y: 0.09%
QGEN - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
QGEN Price to Earnings CAGR:1Y: -28.41%2Y: 0.00%5Y: -3.19%10Y: -11.10%
QGEN - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
QGEN Price To Sales Ratio CAGR:1Y: -22.70%2Y: -7.39%5Y: -5.14%10Y: -0.60%
QGEN - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
QGEN Return on Capital Employed CAGR:1Y: -3.92%2Y: 0.00%5Y: -3.52%10Y: 12.46%
QGEN - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
QGEN Return on Invested Capital CAGR:1Y: 10.55%2Y: 0.00%5Y: -4.18%10Y: 10.54%

Compare stocks side-by-side

QGEN Dividends Info:

Annual Dividend: $0.35
Forward Yield: 0.83%
Ex-Dividend Date: 2026-07-07
Lifetime Dividends / Share: $6.69

QGEN Dividend History: Dates, Payments & Yield list

Below is a schedule of all QGEN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
07/07/202607/09/2026$0.3500.9%0.83%$41.99
01/08/202601/12/2026$2.2904.73%4.85%$47.25
07/02/202507/04/2025$0.2500.51%0.51%$48.55
01/29/202501/29/2025$1.2962.96%2.96%$43.77
01/30/202402/01/2024$1.3583.19%3.15%$43.12
01/25/201701/27/2017$1.14516.35%15.95%$28.72

Projected Future Returns & Dividends for QGEN

Based on past 10-year performance, here are QGEN growth metrics:

Share price CAGR of +3.89%
Dividend CAGR of -13.37%

Using QGEN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

QGEN (DRIP)QGEN - No DRIP
Current Price$42.04$42.04
Start Shares237.87237.87
Start Value$10,000$10,000
  
After 10 years:
Final Share Count249.39237.87
Dividends Payment$0.08$0.08
Annual Dividends$21$20
Yield on cost0.21%0.20%
Share Price$42.04$42.04
Total Dividends$485$474
Final Value$10,485$10,474

Estimated Future Value + Dividends - QGEN

NOTE: Above numbers are our estimate based on QGEN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Qiagen N.V. (QGEN) had its IPO on 1996-06-28, and is traded on NYSE stock exchange.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

QGEN website: https://www.qiagen.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — QGEN

Value from:
Pay up to today
—
vs current price $42.04
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →